| 摘要 |
Pharmaceutical composition for treating osteoporosis or for treating a medical condition characterized by a decrease in bone density, by restoring bone density to an asymptomatic level, without inducing hypercalciuria, hypercalcemia, or nephrotoxicity, said composition containing the compound, 1 alpha -fluoro-25-hydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol, as active ingredient. |
